Isabelle F. Harvey-Seutcheu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabelle F. Harvey-Seutcheu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- András Tálas
Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
1 shared publication - Charles D. Yeh
Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland
1 shared publication - Christelle Chanez
Department of Biochemistry, University of Zurich, Zurich, Switzerland
1 shared publication - Dominic Mailänder
Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland
1 shared publication - Gerald Schwank
Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
1 shared publication - Jacob Ellery Corn
Institute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- Top Cited Papers
- 12 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6790) , eadz1884
Programmable genome editing in human cells using RNA-guided bridge recombinases
Site-specific insertion of gene-sized DNA fragments remains an unmet need in the field of genome editing. IS110-family serine recombinases have recently been shown to mediate programmable DNA recombination in bacteria by using a bispecific RNA guide (bridge RNA) that simultaneously recognizes target and donor sites. In this work, we have shown that the bridge recombinase ISCro4 is highly active in human cells and provided structural insights into its enhanced activity. Using plasmid- or all-RNA–based delivery, ISCro4 supports programmable multikilobase excisions and inversions and facilitates donor DNA insertion at genomic sites with efficiencies that exceed 6%. Last, we assessed ISCro4 specificity and off-target activity. These results establish a framework for the development of bridge recombinases as next-generation tools for editing modalities that are beyond the capabilities of current technologies.
- 12 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6790) , eadz1884
Top Cited PapersProgrammable genome editing in human cells using RNA-guided bridge recombinases
Site-specific insertion of gene-sized DNA fragments remains an unmet need in the field of genome editing. IS110-family serine recombinases have recently been shown to mediate programmable DNA recombination in bacteria by using a bispecific RNA guide (bridge RNA) that simultaneously recognizes target and donor sites. In this work, we have shown that the bridge recombinase ISCro4 is highly active in human cells and provided structural insights into its enhanced activity. Using plasmid- or all-RNA–based delivery, ISCro4 supports programmable multikilobase excisions and inversions and facilitates donor DNA insertion at genomic sites with efficiencies that exceed 6%. Last, we assessed ISCro4 specificity and off-target activity. These results establish a framework for the development of bridge recombinases as next-generation tools for editing modalities that are beyond the capabilities of current technologies.
- Open Access
Bridging Evolution and Design: Mapping the Diversity of LOV Photosensors
Light-sensitive proteins allow organisms to perceive and respond to their environment, and have diversified over billions of years. Among these, Light–Oxygen–Voltage (LOV) domains are widely distributed photosensors that control diverse physiological processes. Despite their broad biological roles and increasing use in optogenetics, the functional diversity of natural LOV domains and the evolutionary constraints shaping their dynamics remain poorly resolved. A key unresolved problem is how evolution modulates the timescales and efficiencies of LOV photocycles and how this kinetic flexibility relates to biological function. Here we systematically map the photodynamics of 21 natural LOV domains – including 18 previously uncharacterized variants – and one de novo photosensor generated by artificial intelligence-guided protein design. We uncover an exceptional kinetic diversity spanning picoseconds to days and identify distinct functional classes within the LOV family. These patterns holistically reveal that billion years of evolutionary adaptation led to branching photocycle kinetics, matching physiological requirements. Moreover, by extending the natural catalog of LOV photosensors with a de novo designed LOV variant, we demonstrate how computational protein design can access new biophysical niches. This work expands the optogenetic toolkit and offers a framework to dissect and harness the evolutionary design principles of light-responsive proteins.
Open AccessBridging Evolution and Design: Mapping the Diversity of LOV Photosensors
Light-sensitive proteins allow organisms to perceive and respond to their environment, and have diversified over billions of years. Among these, Light–Oxygen–Voltage (LOV) domains are widely distributed photosensors that control diverse physiological processes. Despite their broad biological roles and increasing use in optogenetics, the functional diversity of natural LOV domains and the evolutionary constraints shaping their dynamics remain poorly resolved. A key unresolved problem is how evolution modulates the timescales and efficiencies of LOV photocycles and how this kinetic flexibility relates to biological function. Here we systematically map the photodynamics of 21 natural LOV domains – including 18 previously uncharacterized variants – and one de novo photosensor generated by artificial intelligence-guided protein design. We uncover an exceptional kinetic diversity spanning picoseconds to days and identify distinct functional classes within the LOV family. These patterns holistically reveal that billion years of evolutionary adaptation led to branching photocycle kinetics, matching physiological requirements. Moreover, by extending the natural catalog of LOV photosensors with a de novo designed LOV variant, we demonstrate how computational protein design can access new biophysical niches. This work expands the optogenetic toolkit and offers a framework to dissect and harness the evolutionary design principles of light-responsive proteins.